Cargando…
Inhibitor of p52 NF-κB subunit and androgen receptor (AR) interaction reduces growth of human prostate cancer cells by abrogating nuclear translocation of p52 and phosphorylated AR(ser81)
Accumulating evidence shows that androgen receptor (AR) activation and signaling plays a key role in growth and progression in all stages of prostate cancer, even under low androgen levels or in the absence of androgen in the castration-resistant prostate cancer. Sustained activation of AR under and...
Autores principales: | Mehraein-Ghomi, Farideh, Church, Dawn R., Schreiber, Cynthia L., Weichmann, Ashley M., Basu, Hirak S., Wilding, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633170/ https://www.ncbi.nlm.nih.gov/pubmed/26622945 |
Ejemplares similares
-
Phosphorylation of the androgen receptor at Ser81 is co‐sustained by CDK1 and CDK9 and leads to AR‐mediated transactivation in prostate cancer
por: Gao, XinTao, et al.
Publicado: (2021) -
ECFA/81/52/Rev.6-Terms-of-Reference
Publicado: (2021) -
Study of intermediate velocity products in the $Ar + Ni$ collisions between 52 and 95 A MeV
por: Lefort, T, et al.
Publicado: (1998) -
Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52
por: Joshi, Jugal Bharat, et al.
Publicado: (2017) -
Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer
por: Khan, Farhan, et al.
Publicado: (2023)